Delivery Order SPE2DR25D2003-SPE2DR26FR04N
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $25,316.54 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count packaging) on December 1, 2025, with completion scheduled for December 2, 2025. This firm fixed-price delivery order is not set-aside and represents a competitively awarded transaction under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running...
- The Defense Logistics Agency awarded a $5,164.29 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) on December 18, 2025, with completion scheduled for December 19, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military...
- The Defense Logistics Agency awarded a delivery order valued at $29,812.77 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packages) on September 29, 2025, with completion expected by September 30, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside delivery order for pharmaceutical supply to federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $9,373.75 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packages) on December 15, 2025, with an ultimate completion date of December 16, 2025. This is a firm fixed price, non-set-aside contract with performance in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion prime...
- The Defense Logistics Agency awarded a delivery order valued at $3,884.63 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) on November 13, 2025, with completion scheduled for November 14, 2025. This non-competitive delivery order represents a firm fixed price transaction sourced from AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $7,293.58 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8 count) on November 25, 2025, with completion targeted for November 26, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under the company's existing contract vehicle. The product will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location, where the company maintains its corporate headquarters...
- The Defense Logistics Agency awarded a delivery order valued at $4,200.07 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packaging) on August 7, 2025, with an ultimate completion date of August 8, 2025. This is a firm fixed price delivery order with no set-aside designation, issued under a competitive procurement process. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the company's distribution hub...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 18, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count units) under a firm fixed-price contract valued at $22,466.32. This non-set-aside competitive award represents a child delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026. The product will be...
- The Defense Logistics Agency awarded a $5,520.01 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count supply) on September 16, 2025, with completion expected by September 17, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $10,977.91 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packaging) on September 15, 2025, with an ultimate completion date of September 16, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement. The...
- SPE2DR25D2003Indefinite Delivery Contract
- SPE2DR25D2003-SPE2DR26FR04NDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $35,072.99 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packages) on December 18, 2025, with an ultimate completion date of December 19, 2025. This firm fixed-price contract represents a non-competitive delivery order and leverages AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vehicle running through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. NURTEC ODT is a migraine treatment medication, reflecting the pharmaceutical distribution scope that characterizes AmerisourceBergen's extensive federal medical procurement portfolio. As a major pharmaceutical distributor and critical vendor for military and veteran healthcare systems, AmerisourceBergen regularly supplies brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support Defense Health Agency and other government healthcare customers. This delivery order exemplifies the company's role in fulfilling routine pharmaceutical replenishment needs under its comprehensive global pharmaceutical support contract with DLA.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $35.1k | 12/17/25 |